Related Experiment Video
Updated: Jun 1, 2025

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Navigating Hyperkalaemia- The A-to-H Clinical Strategy.
Sourabh Sharma1, Sanjay Kalra2
1Department of Nephrology, VMMC & Safdarjung Hospital, New Delhi, India.
Hyperkalaemia, a dangerous electrolyte imbalance, requires a structured approach for effective management. The A-to-H method ensures comprehensive care by addressing analytical accuracy, background, clinical context, diagnosis, evaluation, follow-up, guidelines, and health education.
Area of Science:
- Internal Medicine
- Nephrology
- Emergency Medicine
Background:
- Hyperkalaemia, characterized by elevated serum potassium, is a life-threatening condition.
- Effective management necessitates a systematic and comprehensive approach to avoid critical omissions.
Purpose of the Study:
- To introduce a structured A-to-H (Analytical accuracy, Background, Clinical context, Diagnosis and drugs, Evaluation, Follow-up, Guidelines adherence, Health education) approach for managing hyperkalaemia.
- To provide clinicians with a detailed framework for assessing and managing hyperkalaemia in diverse clinical settings.
Main Methods:
- The A-to-H approach is a systematic framework designed for clinical application.
- Each component of the A-to-H approach is explained in detail to guide healthcare professionals.
Main Results:
- The A-to-H approach ensures that all critical aspects of hyperkalaemia management are considered.
- Implementation of this structured method aims to improve patient outcomes by preventing neglect of key management steps.
Conclusions:
- A systematic and overarching approach is crucial for the effective management of hyperkalaemia.
- The A-to-H framework offers a detailed and organized method for clinicians to manage hyperkalaemia, ensuring comprehensive patient care.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...

